TABLE 1. PROBABILITY OF DEVELOPING INVASIVE CANCER DURING SELECTED AGE GROUPS (%)
TABLE 2. MEDIAN MONTHLY PRICE OF GENERIC AND BRANDED CANCER MEDICINES
TABLE 3. GLOBAL ENGINEERED T CELLS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 4. ENGINEERED T CELLS MARKET FOR CAR MODIFIED T CELLS, BY REGION, 2014-2022 ($MILLION)
TABLE 5. ENGINEERED T CELLS MARKET FOR TCR MODIFIED T CELLS, BY REGION, 2014-2022 ($MILLION)
TABLE 6. ENGINEERED T CELLS MARKET FOR TUMOR INFILTRATING LYMPHOCYTES, BY REGION, 2014-2022 ($MILLION)
TABLE 7. GLOBAL ENGINEERED T CELLS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 8. ENGINEERED T CELLS MARKET FOR LUNG CANCER, BY REGION, 2014-2022 ($MILLION)
TABLE 9. ENGINEERED T CELLS MARKET FOR BREAST CANCER, BY REGION, 2014-2022 ($MILLION)
TABLE 10. ENGINEERED T CELLS MARKET FOR COLORECTAL CANCER, BY REGION, 2014-2022 ($MILLION)
TABLE 11. ENGINEERED T CELLS MARKET FOR MELANOMA, BY REGION, 2014-2022 ($MILLION)
TABLE 12. ENGINEERED T CELLS MARKET FOR LEUKEMIA, BY REGION, 2014-2022 ($MILLION)
TABLE 13. ENGINEERED T CELLS MARKET FOR OTHER APPLICATIONS, BY REGION, 2014-2022 ($MILLION)
TABLE 14. GLOBAL ENGINEERED T CELLS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 15. ENGINEERED T CELLS MARKET FOR HOSPITALS, BY REGION, 2014-2022 ($MILLION)
TABLE 16. ENGINEERED T CELLS MARKET FOR CANCER RESEARCH CENTERS, BY REGION, 2014-2022 ($MILLION)
TABLE 17. ENGINEERED T CELLS MARKET FOR CLINICS, BY REGION, 2014-2022 ($MILLION)
TABLE 18. ENGINEERED T CELLS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 19. NORTH AMERICA ENGINEERED T CELLS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 20. NORTH AMERICA ENGINEERED T CELLS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 21. NORTH AMERICA ENGINEERED T CELLS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 22. NORTH AMERICA ENGINEERED T CELLS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 23. U.S. ENGINEERED T CELLS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 24. U.S. ENGINEERED T CELLS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 25. U.S. ENGINEERED T CELLS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 26. CANADA ENGINEERED T CELLS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 27. CANADA ENGINEERED T CELLS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 28. CANADA ENGINEERED T CELLS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 29. MEXICO ENGINEERED T CELLS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 30. MEXICO ENGINEERED T CELLS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 31. MEXICO ENGINEERED T CELLS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 32. EUROPEAN ENGINEERED T CELLS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 33. EUROPEAN ENGINEERED T CELLS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 34. EUROPEAN ENGINEERED T CELLS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 35. EUROPEAN ENGINEERED T CELLS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 36. GERMANY ENGINEERED T CELLS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 37. GERMANY ENGINEERED T CELLS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 38. GERMANY ENGINEERED T CELLS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 39. FRANCE ENGINEERED T CELLS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 40. FRANCE ENGINEERED T CELLS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 41. FRANCE ENGINEERED T CELLS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 42. UK ENGINEERED T CELLS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 43. UK ENGINEERED T CELLS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 44. UK ENGINEERED T CELLS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 45. ITALY ENGINEERED T CELLS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 46. ITALY ENGINEERED T CELLS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 47. ITALY ENGINEERED T CELLS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 48. SPAIN ENGINEERED T CELLS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 49. SPAIN ENGINEERED T CELLS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 50. SPAIN ENGINEERED T CELLS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 51. REST OF EUROPE ENGINEERED T CELLS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 52. REST OF EUROPE ENGINEERED T CELLS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 53. REST OF EUROPE ENGINEERED T CELLS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 54. ASIA-PACIFIC ENGINEERED T CELLS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 55. ASIA-PACIFIC ENGINEERED T CELLS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 56. ASIA-PACIFIC ENGINEERED T CELLS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 57. ASIA-PACIFIC ENGINEERED T CELLS MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 58. JAPAN ENGINEERED T CELLS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 59. JAPAN ENGINEERED T CELLS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 60. JAPAN ENGINEERED T CELLS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 61. CHINA ENGINEERED T CELLS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 62. CHINA ENGINEERED T CELLS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 63. CHINA ENGINEERED T CELLS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 64. INDIA ENGINEERED T CELLS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 65. INDIA ENGINEERED T CELLS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 66. INDIA ENGINEERED T CELLS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 67. AUSTRALIA ENGINEERED T CELLS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 68. AUSTRALIA ENGINEERED T CELLS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 69. AUSTRALIA ENGINEERED T CELLS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 70. SOUTH KOREA ENGINEERED T CELLS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 71. SOUTH KOREA ENGINEERED T CELLS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 72. SOUTH KOREA ENGINEERED T CELLS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 73. TAIWAN ENGINEERED T CELLS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 74. TAIWAN ENGINEERED T CELLS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 75. TAIWAN ENGINEERED T CELLS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 76. REST OF ASIA-APCIFIC ENGINEERED T CELLS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 77. REST OF ASIA-APCIFIC ENGINEERED T CELLS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 78. REST OF ASIA-APCIFIC ENGINEERED T CELLS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 79. LAMEA ENGINEERED T CELLS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 80. LAMEA ENGINEERED T CELLS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 81. LAMEA ENGINEERED T CELLS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 82. LAMEA ENGINEERED T CELLS MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 83. BRAZIL ENGINEERED T CELLS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 84. BRAZIL ENGINEERED T CELLS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 85. BRAZIL ENGINEERED T CELLS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 86. TURKEY ENGINEERED T CELLS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 87. TURKEY ENGINEERED T CELLS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 88. TURKEY ENGINEERED T CELLS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 89. SAUDI ARABIA ENGINEERED T CELLS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 90. SAUDI ARABIA ENGINEERED T CELLS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 91. SAUDI ARABIA ENGINEERED T CELLS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 92. SOUTH AFRICA ENGINEERED T CELLS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 93. SOUTH AFRICA ENGINEERED T CELLS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 94. SOUTH AFRICA ENGINEERED T CELLS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 95. REST OF LAMEA ENGINEERED T CELLS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 96. REST OF LAMEA ENGINEERED T CELLS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 97. REST OF LAMEA ENGINEERED T CELLS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 98. AUTOLUS LIMITED: COMPANY SNAPSHOT
TABLE 99. BELLICUM PHARMACEUTICALS: COMPANY SNAPSHOT
TABLE 100. BELLICUM PHARMACEUTICALS: PRODUCT PORTFOLIO
TABLE 101. CELL MEDICA LIMITED: COMPANY SNAPSHOT
TABLE 102. CELL MEDICA LIMITED: OPERATING SEGMENTS
TABLE 103. CELL MEDICA LIMITED: PRODUCT PORTFOLIO
TABLE 104. LILLY: COMPANY SNAPSHOT
TABLE 105. LILLY: OPERATING SEGMENTS
TABLE 106. GILEAD SCIENCE INC.: COMPANY SNAPSHOT
TABLE 107. GILEAD SCIENCE INC.: OPERATING SEGMENTS
TABLE 108. GILEAD SCIENCE, INC.: PRODUCT PORTFOLIO
TABLE 109. JUNO THERAPEUTICS, INC.: COMPANY SNAPSHOT
TABLE 110. JUNO THERAPEUTICS, INC.: PRODUCT PORTFOLIO
TABLE 111. NOVARTIS: COMPANY SNAPSHOT
TABLE 112. NOVARTIS: OPERATING SEGMENTS
TABLE 113. NOVARTIS: PRODUCT PORTFOLIO
TABLE 114. KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 115. OXFORD BIOMEDICA: COMPANY SNAPSHOT
TABLE 116. OXFORD BIOMEDICA: OPERATING SEGMENTS
TABLE 117. OXFORD BIOMEDICA: PRODUCT PORTFOLIO
TABLE 118. PFIZER: COMPANY SNAPSHOT
TABLE 119. PFIZER: OPERATING SEGMENTS
TABLE 120. PFIZER: PRODUCT PORTFOLIO
TABLE 121. PRECISION BIOSCIENCES: COMPANY SNAPSHOT
TABLE 122. PRECISION BIOSCIENCES: OPERATING SEGMENT

LIST OF FIGURE

FIGURE 1. MARKET SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS
FIGURE 3. TOP PLAYER POSITIONING: ENGINEERED T CELLS MARKET, 2016
FIGURE 4. PERCENTAGE OF GOVERNMENT EXPENDITURE ON HEALTHCARE, 2013-2014
FIGURE 5. PERCENTAGE DISTRIBUTION OF POPULATION AGED 65 YEARS AND ABOVE BY REGION: 2015, 2030 AND 2050
FIGURE 6. ESTIMATED NUMBER OF DEATHS DUE TO CANCER, U.S., 2015 AND 2017
FIGURE 7. REIMBURSEMENT STATUS OF CANCER MEDICINES APPROVED IN 2014 AND 2015
FIGURE 8. ENGINEERING PROCESS FOR CAR MODIFIED T CELLS
FIGURE 9. ENGINEERED T CELLS MARKET FOR CAR MODIFIED T CELLS, BY COUNTRY, 2016 (%)
FIGURE 10. ENGINEERED T CELLS MARKET FOR TCR MODIFIED T CELLS, BY COUNTRY, 2016-2023 ($MILLION)
FIGURE 11. ENGINEERED T CELLS MARKET FOR TUMOR INFILTRATING LYMPHOCYTES, BY COUNTRY, 2016-2023 ($MILLION)
FIGURE 12. ENGINEERED T CELLS MARKET FOR LUNG CANCER, BY COUNTRY, 2016-2023 ($MILLION)
FIGURE 13. ENGINEERED T CELLS MARKET FOR BREAST CANCER, BY COUNTRY, 2016-2023 ($MILLION)
FIGURE 14. ENGINEERED T CELLS MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2016-2023 ($MILLION)
FIGURE 15. ENGINEERED T CELLS MARKET FOR MELANOMA, BY COUNTRY, 2016-2023 ($MILLION)
FIGURE 16. ENGINEERED T CELLS MARKET FOR LEUKEMIA, BY COUNTRY, 2016-2023 ($MILLION)
FIGURE 17. ENGINEERED T CELLS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2016-2023 ($MILLION)
FIGURE 18. ENGINEERED T CELLS MARKET FOR HOSPITALS, BY COUNTRY, 2016-2023 ($MILLION)
FIGURE 19. ENGINEERED T CELLS MARKET FOR CANCER RESEARCH CENTERS, BY COUNTRY, 2016-2023 ($MILLION)
FIGURE 20. ENGINEERED T CELLS MARKET FOR CLINICS, BY COUNTRY, 2016-2023 ($MILLION)
FIGURE 21. U.S. ENGINEERED T CELLS MARKET, 2016-2023 ($MILLION)
FIGURE 22. CANADA ENGINEERED T CELLS MARKET, 2016-2023 $MILLION)
FIGURE 23. MEXICO ENGINEERED T CELLS MARKET, 2016-2023 ($MILLION)
FIGURE 24. GERMANY ENGINEERED T CELLS MARKET, 2016-2023 ($MILLION)
FIGURE 25. FRANCE ENGINEERED T CELLS MARKET, 2016-2023 ($MILLION)
FIGURE 26. UK ENGINEERED T CELLS MARKET, 2016-2023 ($MILLION)
FIGURE 27. ITALY ENGINEERED T CELLS MARKET, 2016-2023 ($MILLION)
FIGURE 28. SPAIN ENGINEERED T CELLS MARKET, 2016-2023 ($MILLION)
FIGURE 29. REST OF EUROPE ENGINEERED T CELLS MARKET, 2016-2023 ($MILLION)
FIGURE 30. JAPAN ENGINEERED T CELLS MARKET, 2016-2023 ($MILLION)
FIGURE 31. CHINA ENGINEERED T CELLS MARKET, 2016-2023 ($MILLION)
FIGURE 32. INDIA ENGINEERED T CELLS MARKET, 2016-2023 ($MILLION)
FIGURE 33. AUSTRALIA ENGINEERED T CELLS MARKET, 2016-2023 ($MILLION)
FIGURE 34. SOUTH KOREA ENGINEERED T CELLS MARKET, 2016-2023 ($MILLION)
FIGURE 35. TAIWAN ENGINEERED T CELLS MARKET, 2016-2023 ($MILLION)
FIGURE 36. REST OF ASIA-PACIFIC ENGINEERED T CELLS MARKET, 2016-2023 ($MILLION)
FIGURE 37. BRAZIL ENGINEERED T CELLS MARKET, 2016-2023 ($MILLION)
FIGURE 38. TURKEY ENGINEERED T CELLS MARKET, 2016-2023 ($MILLION)
FIGURE 39. SAUDI ARABIA ENGINEERED T CELLS MARKET, 2016-2023 ($MILLION)
FIGURE 40. SOUTH AFRICA ENGINEERED T CELLS MARKET, 2016-2023 ($MILLION)
FIGURE 41. REST OF LAMEA ENGINEERED T CELLS MARKET, 2016-2023 ($MILLION)
FIGURE 42. BELLICUM PHARMACEUTICALS: NET SALES, 2014-2016 ($MILLION)
FIGURE 43. LILLY: NET SALES, 2014-2016 ($MILLION)
FIGURE 44. LILLY: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 45. LILLY: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 46. GILEAD SCIENCE INC.: NET SALES, 2014-2016 ($MILLION)
FIGURE 47. GILEAD SCIENCE INC.: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 48. GILEAD SCIENCE INC.: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 49. JUNO THERAPEUTICS, INC.: NET SALES, 2014-2016 ($MILLION)
FIGURE 50. NOVARTIS: NET SALES, 2014-2016 ($MILLION)
FIGURE 51. NOVARTIS: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 52. NOVARTIS: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 53. OXFORD BIOMEDICA: NET SALES, 2014-2016 ($MILLION)
FIGURE 54. OXFORD BIOMEDICA: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 55. OXFORD BIOMEDICA: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 56. PFIZER: NET SALES, 2014-2016 ($MILLION)
FIGURE 57. PFIZER: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 58. PFIZER: REVENUE SHARE BY GEOGRAPHY, 2016 (%)